Vaxil Bio Ltd VXLLF
Trading Information
- Previous Close Price
- $0.11
- Day Range
- $0.03–0.03
- 52-Week Range
- $0.01–0.50
- Bid/Ask
- $0.03 / $1.77
- Shares Outstanding
- 3.98M
- Market Cap
- $107,568.54
- Volume/Avg
- 1,090 / 1,444
Key Statistics
- Price/Earnings (Normalized)
- 0.25
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Vaxil Bio Ltd is a biotechnology company focused on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. In recent years, the Company has been more focused on P-EsbpDOX. The Company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidates.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.vaxil-bio.com
Valuation
|
Metric
|
VXLLF
|
|---|---|
Price/Earnings (Normalized) | 0.25 |
Price/Book Value | 0.14 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
VXLLF
Financial Strength
|
Metric
|
VXLLF
|
|---|---|
Quick Ratio | 17.97 |
Current Ratio | 17.97 |
Interest Coverage | — |
Quick Ratio
VXLLF
Profitability
|
Metric
|
VXLLF
|
|---|---|
Return on Assets (Normalized) | 35.74% |
Return on Equity (Normalized) | 37.91% |
Return on Invested Capital (Normalized) | 34.85% |
Return on Assets
VXLLF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|%?z<lh | LOCK|bK<q> | $128B | |||
| Moderna Inc
MRNA
| LOCK|&C!Q@?P | LOCK|F@? | $78B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|FvlS@f& | LOCK|zd#c | $76B | |||
| argenx SE ADR
ARGX
| LOCK|^hlbQyc | LOCK|mK | $59B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|>w?<f^ | LOCK|@! | $42B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|@$^!Fb | LOCK|K$%%g | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|nx%?<khs | LOCK|mp&c# | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|#@cRn@ | LOCK|H&^ | $24B | |||
| Incyte Corp
INCY
| LOCK|NCpJBn< | LOCK|ZCL | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|!bqL%x | LOCK|@k< | $15B |
United States